Elastic: A Phase Ib Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. 

Trial Documents

Links to the current protocol, Patient Information Sheet, Informed Consent Form are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the Elastic Trial Office.

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control List. Links to the Version Control Lists used in this trial are below in reverse date order.




Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.


Other Trial Documents


To date there are no publications for this trial.

News and Events

No current news or upcoming events

Contact Details

Chief Investigator

Dr Alexander Sternberg
Consultant Haematologist
Great Western Hospital NHS Foundation Trust
Marlborough Road
Tel: 01793 605004
Fax: 01793 604292
Email: alexander.sternberg@imm.ox.ac.uk


Elastic Trial Office
Trial Coordinator:                             Yolande Jefferson                               
Trial Monitor:                                    Poonam Patel
Trial Management Team Leader:    Shamyla Siddique

Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
B15 2TT

Telephone: +44 (0)121 415 9179
Fax:             +44 (0)121 414 6061
Email:         elastic@trials.bham.ac.uk

Trial Entry
Telephone: +44 (0)121 415 9179                        (9.00 am till 5.00 pm Monday to Friday)

Serious Adverse Event Reporting
Fax: +44 (0)121 414 6061        or  0121 414 3700


The trial is sponsored by the University of Birmingham.

The trial is being conducted under the auspices of the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham according to their local procedures.